Dear Editor, Norepinephrine (NE), also known as noradrenaline, is an important neurotransmitter that plays crucial roles in the central nervous system, including the regulation of mood, memory, and alertness. It also functions as a key hormone in the whole body. In the brain, NE transporter (NET, encoded by the SLC6A2 gene), a Na + /Cl-dependent transporter, reuptakes released NE at neuron synapses, thus maintaining NE homeostasis. Due to the important functions of NET, many drugs targeting NET have been developed to treat various neurological disorders. 1 Despite previous efforts using NET surrogate to gain insights into the transport mechanism, 2 the specific recognition of NE and the mechanistic details of the transport process remain elusive. Moreover, the binding modes of several FDA-approved NET-selective inhibitors require further investigations to provide a solid model for future structurebased drug discovery. In this study, we report high-resolution cryo-EM structures of human NET (hNET) bound with different ligands in three distinct states: an NE-bound inward-open state, an NE-bound occluded state, and an outward-open state bound with inhibitors. These structures reveal intricate details of NE recognition and inhibitor binding, and highlight the significant involvement of water molecules in such recognition process. The comparison of conformations of three different states provides mechanistic insights into the transport process mediated by hNET. We first attached a FLAG-avi tag to the N-terminus of full-length hNET and an N-terminal truncated version, hNET (47-617), and then purified the proteins in the presence of different ligands. Some populations of purified proteins were found to be highly glycosylated (Supplementary information, Fig. S1a, b). The yield and purity of FLAG-avi-hNET (47-617) (denoted as hNETcryo) were better and hNETcryo exhibited similar transport activity for NE and displayed similar sensitivities to different inhibitors compared to wild-type (WT) hNET (Supplementary information, Figs. S2a, c and S3). Therefore, hNETcryo purified in detergent was used for further cryo-EM analysis. To facilitate cryo-EM studies, we performed nanobody screenings (details are provided in Supplementary information) and chose two hits after extensive validations. Nb_BF9, screened using NE-bound hNETcryo, did not interact with inhibitor-bound hNET (data not shown). Therefore, Nb_BF9 was only used to form a complex with hNETcryo_NE. Another hit Nb_BB4, obtained using reboxetine-bound hNET, can form complexes with hNETcryo_NE, hNETcryo_reboxetine, and hNET-cryo_atomoxetine (Supplementary information, Fig. S1c). These two nanobodies were able to attenuate the transport activity of NE (Supplementary information, Fig. S2b) while displaying selective binding properties, suggesting that they are conformation-specific binders.